---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-218868"
form_type: "8-K"
ticker: "URGN"
cik: "0001668243"
company_name: "UroGen Pharma Ltd."
filed_at: "2024-09-13T23:59:59+00:00"
generated_at: "2026-05-31T04:55:26.486065+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Director Fred E. Cohen resigns from UroGen Pharma board effective immediately

## Summary
- Fred E. Cohen resigned as director on Sept 12, 2024.
- Resignation is not due to any disagreement with the company.
- No replacement director has been announced.
- Dr. Cohen's departure is effective immediately.

## SEC filing metadata
- accession: 0001193125-24-218868
- form_type: 8-K
- ticker: URGN
- cik: 0001668243
- company_name: UroGen Pharma Ltd.
- filed_at: 2024-09-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1668243/000119312524218868/0001193125-24-218868-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1668243/000119312524218868/d851871d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-218868
- JSON: https://secwatch.observer/filing/0001193125-24-218868.json
- Plain text: https://secwatch.observer/filing/0001193125-24-218868.txt

## Key facts
- Executive change
  Fred E. Cohen resigned as Director at UroGen Pharma Ltd..
  - Action: resigned
  - Role: Director
  source text: On September 12, 2024, Fred E. Cohen, M.D., D.Phil., notified UroGen Pharma Ltd. (the “Company”) of his resignation as a director of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1668243/000119312524218868/0001193125-24-218868-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.